Experience with belatacept rescue therapy in kidney transplant recipients
Author:
Affiliation:
1. Division of Nephrology; Department of Internal Medicine; Charité Campus Mitte; Berlin Germany
2. Department of Nephrology and Hypertension; University Erlangen-Nürnberg; Erlangen Germany
Publisher
Frontiers Media SA
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12822/fullpdf
Reference43 articles.
1. Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation;Liefeldt;Am J Transplant,2012
2. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm;Gaston;Clin J Am Soc Nephrol,2009
3. The natural history of chronic allograft nephropathy;Nankivell;N Engl J Med,2003
4. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation;Opelz;Transplantation,2009
5. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure;Einecke;Am J Transplant,2009
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Belatacept based immunosuppression: What and when to combine?;Transplant Immunology;2024-08
2. Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2023-12
3. Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy;Journal of Clinical Medicine;2023-10-21
4. Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients;Transplant Immunology;2023-10
5. Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study;Journal of Clinical Medicine;2023-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3